Free shipping on orders over $99*

Take $30 off 4-pack with code Phyllotex30 here

For visual reference only; actual product may vary

  • US Name:

    Savella

  • Alternative Names:

    Miln-Avenir

  • Active Ingredients:

    Milnacipran

  • Brand Manufacturer:

    BioAvenir

  • Manufacturer Location:

    Switzerland

  • Click here to view Product Insert

  • Click here to view Product Insert

Savella *

For visual reference only; actual product may vary

Prescription Required
All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

Miln-AvenirSavella is a serotonin–norepinephrine reuptake inhibitor (SNRI) approved for the management of fibromyalgia, a condition characterized by chronic widespread pain and  tenderness in localized areas.

Place your order

Miln-Avenir Brand 50mg
56 Capsules
-
+
Our price:
$40.00
Miln-Avenir Brand 25mg
56 Capsules
-
+
Our price:
$30.00

*Please note all prices are in US dollars
Miln-AvenirSavella (generic name: milnacipran) is approved for the management of fibromyalgia, a chronic condition characterized by widespread musculoskeletal pain, fatigue, and sleep disturbances. Savella belongs to the pharmacological class of serotonin-norepinephrine reuptake inhibitors (SNRIs), which modulate the balance of neurotransmitters in the central nervous system. This mechanism helps to reduce pain perception and improve overall physical functioning. The drug works by inhibiting the reuptake of serotonin and norepinephrine, two key neurotransmitters that play an essential role in pain regulation and mood stabilization. By maintaining higher levels of these neurotransmitters in the synaptic cleft, Savella is thought to attenuate central sensitization, which contributes to chronic pain. Additionally, the modulation of these neurotransmitters may influence other symptoms associated with fibromyalgia, such as mood disturbances and sleep irregularities. An important feature of Savella is its targeted action on the central nervous system without exerting the sedative effects often seen with other pain management therapies. Milnacipran‘s therapeutic benefits extend to improving physical function and reducing the severity of pain, thereby enhancing quality of life in patients with fibromyalgia. The medication is designed to be taken once or twice daily depending on the clinical scenario, and it offers a controlled approach to managing symptoms without immediately altering the disease course. As an SNRI, Savella is distinct from conventional analgesics, providing an evidence-based option for individuals whose pain is thought to be driven by abnormal central processing. For additional information regarding fibromyalgia and its management, see this overview on fibromyalgia. Although Savella is primarily indicated for fibromyalgia, its effects on neurotransmitter levels have led to studies into its use in treating Major Depressive Disorder (MDD) and social anxiety. Although it is authorized for treatment of these conditions in some other countries, its use in for these conditions in the US remains off-label.  

Dosage and Administration

Savella is administered orally in capsule form and is prescribed according to a tailored dosing regimen based on patient-specific factors and clinical response. The typical regimen involves an initial titration phase to minimize potential adverse reactions and improve tolerability, followed by a maintenance phase with a stable daily dose. The titration period allows the patient’s body to gradually adjust to the medication, potentially reducing the risk of side effects such as nausea or headache. If a dose is missed, the guidance is generally to take the missed dose as soon as it is remembered, unless it is almost time for the next scheduled dose. In such cases, the missed dose should be skipped, and the regular dosing schedule should be resumed. It is important to maintain a consistent daily schedule to ensure stable blood levels of the drug, which is critical for its therapeutic effect. Patients are advised to consult with their healthcare provider regarding any dosing concerns to avoid any disruptions in their treatment plan.

Storage Guidelines

Savella should be stored in a secure, dry place away from direct sunlight, at room temperature, between 68°F to 77°F (20°C to 25°C). It is recommended that Savella is kept in its original container to protect it from environmental factors and accidental damage. The container should remain tightly closed when not in use to prevent contamination.

Common Questions About Savella

How does milnacipran differ from other pain management medications?
Unlike conventional analgesics that primarily target pain at its source, milnacipran works by modulating central pain processing. This unique mechanism as an SNRI means that it not only addresses pain but also contributes to improved mood and sleep patterns. Its dual-action effect distinguishes it from other treatments, providing a more comprehensive approach to managing fibromyalgia symptoms. Milnacipran’s impact on neurotransmitter levels helps to lessen the heightened sensitivity to pain often experienced by patients. This results in better overall management of chronic pain and improved quality of life.
How does managing fibromyalgia with Savella improve quality of life?
Managing fibromyalgia with Savella can lead to significant improvements in quality of life by reducing chronic pain and enhancing sleep quality. Patients often experience less fatigue and better overall physical functioning, which allows for increased participation in daily activities. The modulation of neurotransmitter levels not only alleviates pain but also helps stabilize mood, reducing symptoms of depression and anxiety commonly associated with fibromyalgia. This comprehensive symptom control facilitates improved social and occupational functioning.
What are serotonin–norepinephrine reuptake inhibitors (SNRIs), and how do they work?
SNRIs are a class of medications that work by inhibiting the reuptake of the neurotransmitters serotonin and norepinephrine in the brain. This results in increased concentrations of these chemicals in the synaptic cleft, which helps to regulate mood and pain perception. SNRIs are used in various conditions, including depression and chronic pain disorders like fibromyalgia. Their dual mechanism of action allows them to address multiple symptoms simultaneously, offering a comprehensive treatment option.

This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication. 

Read the information leaflet that comes with the medication.

If a sudden allergic reaction (anaphylaxis) occurs after taking Savella, with symptoms like swelling of the face, tongue, or throat making it difficult to breathe or swallow, or there is wheezing, hives, rash, blistering, or peeling of the skin, call a doctor or 911 right away, or go to an emergency room immediately.

Symptoms suggestive of severe cardiovascular events, such as chest pain or significant changes in heart rhythm, require urgent attention.

Most people who use Savella do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.

Some of the side effects that have been reported include nausea, constipation, headache, dizziness, and increased sweating. Other frequently reported effects may involve insomnia or disturbances in sleep patterns. In some cases, patients might experience elevated blood pressure or heart rate. Although these side effects are generally mild to moderate, monitoring by a healthcare provider is advisable to ensure that they do not progress.

Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.

Savella is primarily approved for the management of fibromyalgia in adults

Fibromyalgia is characterized by chronic widespread pain, tenderness in localized areas, and a host of other symptoms such as fatigue, sleep disturbances, and cognitive difficulties often referred to as “fibro fog.” Patients with fibromyalgia may also experience headaches, irritable bowel syndrome, and mood disorders. The condition is believed to involve abnormal pain processing in the central nervous system, where heightened sensitivity to pain signals is common.

Savella can be prescribed off-label for chronic depression and social anxiety; however, it is only approved for treatment of fibromyalgia in the US.

  • Can Savella be used in combination with other therapies for fibromyalgia?
    Savella is frequently integrated into a broader treatment strategy for fibromyalgia that may include physical therapy, exercise, and behavioral interventions. This multidisciplinary approach aims to address the complex and multifaceted nature of fibromyalgia. When combined with non-pharmacological therapies, Savella’s ability to alleviate pain and improve mood can enhance the overall effectiveness of the treatment plan
  • What are the benefits of using SNRIs for fibromyalgia?
    The benefits of using SNRIs for fibromyalgia include a reduction in widespread pain, improvement in mood, and enhanced sleep quality. By increasing serotonin and norepinephrine levels, these medications help modulate the body’s pain response and alleviate the heightened pain sensitivity seen in fibromyalgia patients. Additionally, SNRIs can contribute to overall improvements in physical function and quality of life, making them a valuable component of a comprehensive fibromyalgia treatment plan
  • Are there any special considerations when prescribing SNRIs like Savella?
    When prescribing SNRIs such as Savella, healthcare providers consider a range of factors including the patient’s overall medical history, potential drug interactions, and the presence of coexisting conditions. Special attention is given to the titration process to minimize side effects, and patients are monitored regularly to assess therapeutic response and adjust dosing if necessary. This careful approach helps optimize the benefits of treatment while minimizing risks, ensuring that patients receive a tailored and effective therapy for their condition.

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Fast delivery
Secure payment
Genuine brands
Pharmacist oversight
Proudly Israeli

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Read more from our blog

Arcoxia A Targeted Approach to Safer Pain Management

Arcoxia: A Targeted Approach to Safer Pain Management

Pain management has long relied on non-selective nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil), naproxen (Naprosyn), aspirin (Aspirin), and diclofenac (Voltaren. Betaren), but these medications often come with significant gastrointestinal (GI) risks. Arcoxia (generic

Read More »

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email